# YCANTH
> **NDA212905** · New Drug Application · Sponsor: VERRICA PHARMS · Approved 2023-07-21
## Drug
- **FDA Application Number:** NDA212905
- **Application type:** New Drug Application
- **Brand name:** YCANTH
- **Generic name:** CANTHARIDIN
- **Active ingredients:** CANTHARIDIN
- **Dosage form:** SOLUTION
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** VERRICA PHARMS
- **Manufacturer:** Verrica Pharmaceuticals Inc.
- **First approval:** 2023-07-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212905)
---
*AI Analytics · CC0 1.0*